French digital radiography developer Biospace Med of Paris has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a 3D skeletal reconstruction mode for its EOS digital x-ray system.
sterEOS is designed to enable EOS to perform 3D skeletal reconstructions for applications such as visualizing spine pathologies and hip and knee arthropathies. The EOS system captures head-to-toe images of patients in a standing, weight-bearing position at reduced radiation dose. The system received FDA clearance in 2007.
sterEOS includes a 3D visualization workstation and is designed to reduce surgical planning time and help establish an effective course of treatment.
Related Reading
Biospace adds Latin American distributor, November 30, 2007
Biospace raises $18 million, November 27, 2007
Biospace adds to executive lineup, November 19, 2007
Road to RSNA, Digital X-Ray, Biospace Med, October 23, 2007
Biospace Med nets FDA OK on x-ray imager, October 9, 2007
Copyright © 2008 AuntMinnie.com
